[1]
Bao J, Zhang Q, Duan T, et al. The fate of nanoparticles in vivo and the strategy of designing stealth nanoparticle for drug delivery. Current Drug Targets 2021; 22(8): 922-46.
[http://dx.doi.org/10.2174/1389450122666210118105122]
[http://dx.doi.org/10.2174/1389450122666210118105122]
[2]
Sethuraman V, Janakiraman K, Krishnaswami V, et al. Recent progress in stimuli responsive intelligent nano scale drug delivery systems: a special focus towards pH sensitive systems. Current Drug Targets 2021; 22(8): 947-66.
[http://dx.doi.org/10.2174/1389450122999210128180058]
[http://dx.doi.org/10.2174/1389450122999210128180058]
[3]
Lou XF, Du YZ, Xu XL. Endogenous enzyme-responsive nanoplatforms for anti-tumor therapy. Current Drug Targets 2021; 22(8): 845-55.
[http://dx.doi.org/10.2174/1389450122666210114095614]
[http://dx.doi.org/10.2174/1389450122666210114095614]
[4]
Wang R, Sha X. Biomimetic drug delivery systems oriented by biological function in tumor targeting. Current Drug Targets 2021; 22(8): 882-95.
[http://dx.doi.org/10.2174/1389450122666210114095859]
[http://dx.doi.org/10.2174/1389450122666210114095859]
[5]
Jiang J. Cell-penetrating peptide-mediated nanovaccine delivery Current Drug Targets. 2021; 22(8): 896-912. .
[http://dx.doi.org/10.2174/1389450122666210203193225]
[http://dx.doi.org/10.2174/1389450122666210203193225]
[6]
Fang W, Su D, Lu W, et al. Application and future prospect of extracellular matrix targeted nanomaterials in tumor theranostics. Current Drug Targets 2021; 22(8): 913-21.
[http://dx.doi.org/10.2174/1389450122666210127100430]
[http://dx.doi.org/10.2174/1389450122666210127100430]
[7]
Al-Amili M, Jin Z, Wang Z, et al. Self-assembled micelles of amphiphilic PEGylated drugs for cancer treatment. Current Drug Targets 2021; 22(8): 870-81.
[http://dx.doi.org/10.2174/1389450122666201231130702]
[http://dx.doi.org/10.2174/1389450122666201231130702]
[8]
Wande DP, Cui Q, Chen S, et al. Rediscovering Tocophersolan: a renaissance for nano-based drug delivery and nanotheranostic applications. Current Drug Targets 2021; 22(8): 856-69.
[http://dx.doi.org/10.2174/1389450121666200611140425]
[http://dx.doi.org/10.2174/1389450121666200611140425]
Article Metrics
7
1